Download PDF - Bentham Open

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Polyclonal B cell response wikipedia , lookup

Globalization and disease wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Germ theory of disease wikipedia , lookup

Adaptive immune system wikipedia , lookup

Atherosclerosis wikipedia , lookup

Immune system wikipedia , lookup

Inflammation wikipedia , lookup

Pathophysiology of multiple sclerosis wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Molecular mimicry wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Phagocyte wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Autoimmunity wikipedia , lookup

Psoriasis wikipedia , lookup

Innate immune system wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Macrophage wikipedia , lookup

Immunomics wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Transcript
76 The Open Conference Proccedings Journal, 2013, Volume 4
Proceedings of the ICNP 2013
OR-62
Immunomodulatory Effects of Zingiber Officinale Roscoe var. Rubrum
(Halia Bara) ON Inflammatory Responses Relevant to Psoriasis
Nurul Izza Nordin1,*, Simon Gibbons2, David Perrett3 and Rizgar A. Mageed4
1
Industrial Biotechnology Research Centre, SIRIM Berhad, 40911 Shah Alam, Malaysia; 2Department of
Pharmaceutical and Biological Chemistry, University College London, WC1N 1AX London, United Kingdom;
3
Translational Medicine and Therapeutics, and 4Bone & Joint Research Unit, Queen Mary University of London, EC1M
6BQ London, United Kingdom; E-mail: [email protected]
This study reveals the therapeutic efficacy and mechanisms of action of the ginger species Halia Bara, or Zingiber officinale
Roscoe var. rubrum (ZOR), on key immunopathogenic mechanisms relevant to psoriasis. It is known that psoriasis is a chronic
autoimmune skin disease characterised by hyperplasia of epidermal keratinocytes and the accumulation of activated immune
cells at sites of the disease. The disease is associated with aberrant activation of phagocytes (such as macrophages), Tlymphocytes and the production of pro-inflammatory cytokines and chemokines. In-depth experiments showed that ZOR
chloroform extract (HB02), its active fraction (F6) and two identified compounds (6-shogaol and 1-dehydro-6-gingerdione)
effectively inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) production by activated macrophages. These effects were
comparable to dexamethasone and indomethacin. More interestingly, ZOR samples at 20 µg/mL strongly down-regulated
mRNA level of iNOS, IL-12p40 and IL-23p19 in pre-treatment experiments of activated macrophages. Further, studies of
immune cell migration showed that F6 and the compounds inhibited the migration of polymorphonuclear neutrophils (PMNs)
through human vascular endothelial cells (HUVEC) by influencing CD11b expression and CD62L shedding. In addition, F6
and the compounds were also shown to modulate activation of CD8+ cytotoxic T-lymphocytes as indicated by reduction of
‘activation markers’, CD25 and CD69 expression. An in vitro model of epidermal inflammation indicated that ZOR samples
directly inhibited keratinocyte proliferation and the production of IL-20 and IL-8, both are key psoriasis-promoting cytokines.
Hence, these experimental evidences substantiate the potential mechanisms of action of ZOR in ameliorating psoriasis.
Keywords: Psoriasis, Zingiber officinale Roscoe var. rubrum (Halia Bara), 6-shogaol, 1-dehydro-6-gingerdione.